We are live on ! Find out more
QI

QS Investors Portfolio holdings

AUM $8.47B
1-Year Est. Return 30.71%
This Fund
S&P 500
This Quarter Est. Return
+6.35%
1 Year Est. Return
+30.71%
3 Year Est. Return
+50.42%
5 Year Est. Return
+87.44%
10 Year Est. Return
AUM
$3.74B
AUM Growth
+$414M
Cap. Flow
+$264M
Cap. Flow %
7.07%
Top 10 Hldgs %
20.11%
Holding
854
New
265
Increased
291
Reduced
203
Closed
80

Top Buys

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$27.3M
2
CI icon
Cigna
CI
+$26.2M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$21.2M
4
PPC icon
Pilgrim's Pride
PPC
+$20M
5
ETR icon
Entergy
ETR
+$19.3M

Sector Composition

Rank Sector Weight
1 Healthcare 10.01%
2 Energy 8.3%
3 Technology 7.58%
4 Industrials 7.07%
5 Financials 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
26
Gilead Sciences
GILD
$162B
$29.4M 0.79%
354,073
-117,900
-25% -$9.18M
CI icon
27
Cigna
CI
$73.7B
$28.7M 0.77%
312,010
+305,560
+4,737% +$26.2M
KMB icon
28
Kimberly-Clark
KMB
$36.3B
$27.6M 0.74%
258,475
-19,762
-7% -$2.1M
PPC icon
29
Pilgrim's Pride
PPC
$6.51B
$27.3M 0.73%
999,300
+840,300
+528% +$20M
T icon
30
AT&T
T
$159B
$27.3M 0.73%
1,020,423
-266,318
-21% -$7.13M
HP icon
31
Helmerich & Payne
HP
$3.45B
$27M 0.72%
232,617
-6,683
-3% -$732K
LUV icon
32
Southwest Airlines
LUV
$22B
$26.6M 0.71%
990,203
-20,797
-2% -$524K
EA icon
33
Electronic Arts
EA
$53B
$25.9M 0.69%
720,938
+465,938
+183% +$15.1M
ILMN icon
34
Illumina
ILMN
$31B
$25.9M 0.69%
148,854
+63,427
+74% +$9.46M
VLO icon
35
Valero Energy
VLO
$90.1B
$24.7M 0.66%
493,276
+4,312
+0.9% +$238K
LMT icon
36
Lockheed Martin
LMT
$134B
$24.3M 0.65%
150,972
-16,991
-10% -$2.76M
ETR icon
37
Entergy
ETR
$50.2B
$23.7M 0.64%
578,516
+516,438
+832% +$19.3M
BSX icon
38
Boston Scientific
BSX
$69.5B
$23.5M 0.63%
1,843,123
+533,481
+41% +$6.94M
DBC icon
39
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$22.3M 0.6%
838,067
+109,142
+15% +$2.88M
WCG
40
DELISTED
Wellcare Health Plans, Inc.
WCG
$22.2M 0.59%
+296,800
New +$21.2M
TSN icon
41
Tyson Foods
TSN
$20.4B
$22M 0.59%
585,992
+28,992
+5% +$1.16M
ABBV icon
42
AbbVie
ABBV
$443B
$21.5M 0.58%
381,404
+102,343
+37% +$5.37M
Y
43
DELISTED
Alleghany Corp
Y
$20.9M 0.56%
47,700
+23,100
+94% +$9.65M
HPQ icon
44
HP
HPQ
$24.9B
$20.8M 0.56%
1,357,815
-10,492
-0.8% -$158K
CVS icon
45
CVS Health
CVS
$133B
$20M 0.54%
266,000
+136,081
+105% +$10.3M
ETFC
46
DELISTED
E*Trade Financial Corporation
ETFC
$20M 0.53%
938,552
-62,048
-6% -$1.3M
PFG icon
47
Principal Financial Group
PFG
$24.3B
$19.5M 0.52%
+386,177
New +$18.2M
EMB icon
48
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$19.5M 0.52%
169,015
+16,317
+11% +$1.85M
HII icon
49
Huntington Ingalls Industries
HII
$12.9B
$19.3M 0.52%
203,800
-37,600
-16% -$3.76M
NOC icon
50
Northrop Grumman
NOC
$77.1B
$17.8M 0.48%
148,409
-67,642
-31% -$8.18M

Similar funds

QS Investors's Q2 2014 Portfolio in Review

As of Q2 2014, QS Investors held 854 positions worth $3.74B, up 12% from $3.32B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

QS Investors deployed $264M of net new capital in Q2 2014, opening 265 new positions and adding to 291 existing holdings. Its largest new stake was Wellcare Health Plans, Inc.: 296,800 shares worth $22.2M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 9.2% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Raytheon Company, an estimated $23.3M trimmed.

  • QS Investors's largest Q2 2014 buy was Wellcare Health Plans, Inc.: 296,800 shares worth $22.2M.
  • QS Investors added most to ConocoPhillips in Q2 2014, an estimated $27.3M increase.
  • QS Investors's biggest Q2 2014 reduction was Raytheon Company, cutting an estimated $23.3M.
  • QS Investors fully exited Waddell & Reed Financial, Inc. in Q2 2014, selling an estimated $24.6M.
  • QS Investors's ten largest holdings make up 20% of its $3.74B portfolio in Q2 2014.
  • QS Investors opened 265 new positions and closed 80 in Q2 2014.
  • QS Investors's portfolio value rose 12% quarter-over-quarter to $3.74B.

Based on QS Investors's 13F filing for Q2 2014, filed 14 Aug 2014.